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Acanthamoeba polyphaga mimivirus tyrosyl-tRNA synthetase (TyrRSapm) was the ﬁrst reported
aminoacyl-tRNA synthetase of viral origin. The previous crystal structure of TyrRSapm showed a
non-canonical orientation of the dimer conformation and the CP1 domain, responsible for dimer
formation, displays a major modiﬁcation of a motif structurally conserved in other TyrRS structures.
An earlier study reported that Bacillus stearothermophilus N-terminal TyrRS exists as a dimer under
native conditions. N-terminal TyrRSapm (DTyrRSapm, 1–234 aa) was constructed to remove the
C-terminal anticodon-binding domain. Here we show by Ferguson plot analysis and analytical ultra-
centrifugation that DTyrRSapm exists as a monomer and contains a disulﬁde-bridge. The DTyrRSapm
loses the ability to bind tRNATyr, however it remains active in pyrophosphate exchange with similar
ligand dissociation constants as the full-length enzyme.
Structured summary of protein interactions:
TyrRSapm and TyrRSapm bind by cosedimentation in solution (View interaction)
TyrRSapm and TyrRSapm bind by blue native page (View interaction)
TyrRSapm and TyrRSapm bind by ﬂuorescence technology (View interaction)
TyrRSapm and TyrRSapm bind by ﬂuorescence technology (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction TyrRS has been associated with several unique features un-Tyrosyl-tRNA synthetase (TyrRS) belongs to class Ic subdomain
and unlike most other monomeric class I aminoacyl-tRNA synthe-
tases (aaRSs), it forms dimers, along with tryptophanyl-tRNA syn-
thetase (TrpRS) [1]. Its main function is to catalyze the attachment
of tyrosine to the 30 end of tRNATyr and this reaction, known as
aminoacylation of tRNA, occurs in two independent steps as shown
below [2].
TyrRSþ L-Tyrþ ATP! TyrRS  L-Tyr-AMPþ PPi ð1Þ
TyrRS  L-Tyr-AMPþ tRNATyr ! TyrRSþ L-Tyrosyl-tRNATyr
þ AMP ð2Þmatched in any other aminoacyl-tRNA synthetases (aaRSs). Among
the 20 canonical aaRSs, TyrRS was the ﬁrst to be crystallized [3]
and one of the early proteins whose mechanism has been studied
thoroughly, using protein engineering, and was found to follow
half-of-site reactivity [4–8]. It was established that human cyto-
solic TyrRS can be split into two parts under apoptotic condition
and the released C-terminal domain exhibits cytokine activity
[9]. Furthermore, Neurospora crassa mitochondrial TyrRS was
reported to have group I intron splicing activity [10]. In humans,
mutation of TyrRS gene is associated with Dominant Intermediate
Charcot-Marie-Tooth Type C (DI-CMTC) disorder, the most com-
mon inherited peripheral neuropathy [11].
To date, the crystal structures of TyrRS from bacterial, viral,
archaeal, parasitic and mammalian sources have been solved
either in free or in the liganded states [12–17]. Another unique
feature of TyrRS is its existence in Acanthamoeba polyphaga mimi-
virus. The genome of A. polyphaga mimivirus encodes four aaRSs,
namely MetRS, TyrRS, ArgRS, and CysRS [17]. The solved crystal
structure of A. polyphaga mimivirus TyrRS (TyrRSapm) displayed
the characteristic tertiary architecture as found in other solved
TyrRS crystals, but forms a non-canonical homodimer [17]. The
crystal structure showed that TyrRSapm consisted of two domains,
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domain contains the Rossmann fold catalytic-domain, typical of
class I synthetases (10–36) and CP1 domain, responsible for
dimerization (121–183), while the C-terminal domain (235–346)
is accountable for tRNA anticodon binding [17]. However, there
are some unique features present in the TyrRSapm structure, par-
ticularly at the dimeric interface. The main idiosyncratic feature is
that when one monomer is superimposed on the corresponding
monomer of other solved crystal structure of TyrRSs having
canonical dimeric interface, the second monomer lies nearly at
90 angle relative to its position in the crystal of other dimeric
proteins [17]. The second difference is the presence of a single
20-residue-long extended helix (a7, 129–148) in CP1 domain,
rather than 14-residue-long a-helix followed by a 90 turn and
a 9-residue-long helix present in the crystal structures of all
solved TyrRSs crystal structure having canonical dimeric inter-
faces [17]. The CP1 domain, responsible for dimerization of all re-
ported TyrRS, thus exhibits signiﬁcant alteration in orientation at
the dimeric interface and accountable for non-canonical structure
of TyrRSapm.
Previously, Bacillus stearothermophilus TyrRS (Bst-TyrRS) (full-
length 1–419) N-terminal fragment (1–317) containing CP1 do-
main (120–181, pdb id: 2TS1) was extensively characterized
and found to be capable of forming highly stable dimer in solu-
tion with a dissociation constant of 84 pM [2,18]. However, the
full-length TyrRS from N. crassa or N-terminal fragment of hu-
man TyrRS was reported to form weaker dimer (dissociation
constant 0.1 lM) due to relatively lesser buried surface area
at the dimer interface of these two proteins compare to Bst-Tyr-
RS [19,20].
The unusual CP1 domain leading to non-canonical dimeric
interface organization of TyrRSapm as well as a probable separate
evolutionary origin representing a possible ‘‘fourth domain’’ of life
[21] and the least buried surface area reported so far at the dimeric
interface for TyrRSapm [17] raises the issue whether it has any
implication on dimerization capability of TyrRSapm in solution.
Additionally, to understand the precise role of non-canonical CP1
domain in dimerization of TyrRSapm, we isolated and characterized
N-terminal domain (DTyrRSapm, residues 1–234 precisely after
class I signature sequence 230KMSKS234) containing the entire N-
terminal fragment including CP1 domain (121–183 aa), while the
anticodon binding domain is absent (235–346) [17].
We here report that TyrRSapm is indeed form weaker dimer in
solution. Surprisingly, DTyrRSapm exists as monomer in solution.
Functionally, monomeric DTyrRSapm is capable of activating tyro-
sine as probed by ATP–PPi exchange assay, however it is inactive
in aminoacylation reaction and the ﬂuorescence quenching study
showed that it binds weakly to tRNATyr. Also a detailed comparison
has been done with TyrRSapm, exploiting different biophysical tech-
niques such as circular dichroism, ﬂuorescence and analytical
ultracentrifugation (AUC).2. Materials and methods
2.1. Materials
The clone of full-length Mimivirus TyrRS (TyrRSapm) was a gift
from Professor Chantal Abergel (Information Génomique et
Structurale, CNRS – IBSM, Marseille, France). All the chemicals used
were of molecular biology grade from Sigma, HI-MEDIA, E-Merck
and SRL. Primers were obtained from Sigma Chemical Company.
Plasmid containing the human tRNATyr gene was a gift from Dr.
Eric First (Louisiana State University Health Sciences Center-School
of Medicine in Shreveport). Fluorescein isothiocyanate (FITC) was
kindly provided by Professor David Jameson, University of Hawaii.2.2. Protein isolation and puriﬁcation
A stop codon was introduced after amino acid number 234 by
point mutation using site-directed mutagenesis, following the
Quick Change procedure (Stratagene). The protein puriﬁcation
was done by a published protocol [17,22] (see Supplementary
information).
2.3. In vitro transcription and puriﬁcation of tRNATyr
The human tRNATyr transcript required for aminoacylation as-
say was puriﬁed according to a recently published protocol by
Dr. Eric First’s group [23].
2.4. Circular dichroism (CD) spectroscopy
The CD spectra were recorded with a JASCO J-815 spectropolar-
imeter, using 20 mM Tris–HCl (pH 7.4) buffer in presence and ab-
sence of b-mercaptoethaol. For secondary structure determination,
4 lM protein samples were monitored in far UV region (200–
250 nm) using 1 mm path length cuvette. The a-helix percentage
was calculated using Mean Residue Ellipticity (MRE) value at
222 nm according to the formula, [(MRE-2340)/30300]  100
[24]. Changes in the tertiary structure of protein samples
(40 lM) were monitored at near UV region (250–350 nm) using
10 mm path length cuvette in the same buffer. Each sample was
scanned for ﬁve times. The scan speed was 50 nm/min. The con-
centrations of TyrRSapm and DTyrRSapm were determined using
the molar absorption coefﬁcient of 40138 M1 cm1 and
21454 M1 cm1 at 280 nm for TyrRSapm and DTyrRSapm, respec-
tively. All the experiments were conducted at 25 C. The ﬁnal spec-
trum was average of three independent measurements.
2.5. Fluorescence spectroscopy
All ﬂuorescence measurements were performed in a HITACHI F-
7000 ﬂuorescence spectroﬂuorometer using a quartz cuvette of
either 0.5 or 1 mm path length. All measurements were repeated
at least three times. Protein concentrations were kept at 27 nM
to 10 lM for all ﬂuorescence measurements. All the ﬂuorescence
samples were excited at 295 nm for selective excitation of trypto-
phan residues. The emission spectra were recorded from 310 nm to
450 nm. Both excitation and emission spectral band widths were
set at 5 nm for all experiments. The buffer used was 20 mM Tris–
HCl pH 7.4 containing 16 mM MgCl2 either in presence or absence
of 10 mM b-mercaptoethanol.
2.6. Active site titration
Active site titration was performed according to the protocol
published recently [25]. Brieﬂy, in a 50 ll reaction mixture con-
taining 100 mM Na-Hepes pH 7.2, 30 mM KCl, 10 mM MgCl2,
2 mM ATP, 25 lM L-[ring, 3,5-3H] Tyr (42.6 Ci/mmol, Perkin Elmer
Lifesciences) and with or without 10 mM b-mercaptoethanol.
Pyrophosphatase (PPase) was also added to ensure unidirectional
formation of aminoacyl adenylate. The reaction was initiated by
the addition of TyrRSapm or DTyrRSapm (2 lM determined spectro-
photometrically) to reaction mixture pre-incubated at 37 C for
5 min. After addition of enzymes in presence or absence of reduc-
ing agent, the reaction was carried out for 10 min at 37 C and then
ﬁltered through a nitrocellulose membrane (Whatman PROTRAN
BA85) pre-washed with cold 1 aminoacylation buffer. The ﬁlters
were then washed with 3 ml cold 1 aminoacylation buffer and
dried at 80 C for 15 min. The amount of radioactivity retained
was quantiﬁed by liquid scintillation counting.
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ATP–PPi exchange reactions were performed at 37 C as de-
scribed [26]. Brieﬂy, the reaction was conducted at 37 C in a
300 ll mixture containing 50 mM Na-Hepes (pH 7.2), 15 mM KCl,
16 mM MgCl2, 2 mM NaF, 2 mM ATP, 2 mM [32P]PPi (1–2 cpm/
pmol), various amounts Tyr (0.2–5 mM), and 20–300 nM TyrRSapm
or DTyrRSapm. The same reaction was performed in presence of
10 mM b-mercaptoethanol. We repeated the reaction in presence
of 2 lM TyrRSapm. After 5–20 min as described previously [17],
20 ll of the reaction mixture were removed and added to a solu-
tion containing 1% charcoal, 5.6% HClO4, and 75 mM PPi. The radi-
olabeled ATP bound to the charcoal was ﬁltered through a 3MM
Whatman ﬁlter disc under vacuum and washed twice with 5 ml
of water and another two times with 5 ml of ethanol. The ﬁlters
were dried, and the radioactivity was counted by liquid scintilla-
tion counting. Control experiments with a mixture of 19 amino
acids (1 mM each) except L-tyrosine were carried out in parallel.
2.8. Protein labeling
For the covalent labeling of TyrRSapm with ﬂuorescein isothiocy-
anate (FITC), a required amount of a concentrated stock solution
(3.6 mM) of the probe was added to a 50 lM TyrRSapm solution
in 100 mM sodium carbonate–bicarbonate buffer (pH 9) to attain
ﬁnal enzyme:probe molar ratio of 1:10. The mixture was incubated
overnight at 4 C, followed by termination of the reaction by addi-
tion of 10 mM b-mercaptoethanol. The labeled protein was sepa-
rated from unbound dye after passing through Sephadex G-25
column equilibrated with the same buffer. The eluted fractions
containing labeled protein were pooled and dialyzed extensively
for 24 h with ﬁve changes in 20 mM Tris–HCl (pH 7.4) buffer con-
taining 16 mM MgCl2 to get rid of excess unbound ﬂuorophores.
The labeling efﬁciency was assessed spectrophotemetrically and
incorporation of probe to protein (F/P) was found to be 1:1. Nec-
essary corrections were performed to negate the contribution of
the probes in absorbance at 280 nm.
2.9. Fluorescence anisotropy
FITC labeled proteins were excited at 490 nm and emission
was recorded at 525 nm. Labeled protein samples were serially
diluted from 4 lM to 2 nM concentration with 20 mM Tris–
HCl (pH 7.4) buffer containing 16 mM MgCl2. For the samples sat-
urated with ligands, 1 mM of L-tyrosine, 2 mM of ATP and 5 lM of
tRNATyr separately or together was ﬁrst incubated with the en-
zyme sample for 30 min at 25 C. While measuring the anisotropy
values at ligand bound condition, serial dilutions were carried out
with the buffer in presence of respective ligand at identical con-
centration, to maintain an unchanged ligand concentration of
the sample throughout the experiment. For all experiments, the
excitation and emission band pass were 5 nm. Measurements
were made by rotating emission polarizer at regular interval to
obtain perpendicular (I\) and parallel (I||) decay components.
The diffraction grating factor G and anisotropy value A were ob-
tained as follows:
G ¼ I?=III A ¼ ðIII  G:I?Þ=ðIII þ 2:G:I?Þ
The dissociation constants were calculated using the method
described elsewhere using Kyplot [27,28].
2.10. tRNA aminoacylation
Aminoacylation was performed at 37 C in aminoacylation buf-
fer (100 mM Na-Hepes (pH 7.2), 30 mM KCl, 2 mM ATP, 10 mM
MgCl2) containing 20 lM L-[ring, 3,5-3H] Tyr (42.6 Ci/mmol, PerkinElmer Lifesciences), 3 lM H. sapiens tRNATyr, and 20 nM to 20 lM
TyrRSapm or DTyrRSapm. 9 ll aliquots were removed and spotted
on 3MM ﬁlter disks (Whatman), washed three times in 10% trichlo-
roacetic acid and dried. The amount of radioactivity retained was
determined by liquid scintillation counting. One unit of TyrRSapm
or DTyrRSapm activity corresponded to the amount of enzyme nec-
essary to catalyze the formation of 1 nmol of Tyr-tRNATyr min1
mg1 protein at 37 C.
2.11. Ferguson plot analysis
See Supplementary information.
2.12. Analytical ultracentrifugation
Sedimentation equilibrium experiments were performed in a
Beckmann XL1-optima ultracentrifuge at 4 C (Beckman-Coulter
Instruments) using An50-Ti rotor. To avoid any suspended contam-
inants, protein samples as well as the reference buffer solutions
were centrifuged at 5000 rpm for 4 min at room temperature in a
tabletop centrifuge before the experiments. 110 ll of each protein
sample was loaded against 120 ll buffer solutions in a 12 mm
charcoal ﬁlled six-chambered EPON centerpiece. TyrRSapm was
centrifuged at 9000 rpm for 70 h and at 12000 rpm for the next
12 h, while sample containing DTyrRSapm, was rotated at
7000 rpm, 10000 rpm, 15000 rpm and 20000 rpm for a total of
96 h for complete attainment of equilibrium. During the entire
experiment, protein samples were kept in 20 mM Tris–HCl (pH
7.4) buffer containing 100 mM NaCl. Data were recorded at
220 nm as a function of radial position at the three loading concen-
trations of 0.2 lM, 0.5 lM and 2 lM for TyrRSapm and 5 lM for
DTyrRSapm in absence and presence of 10 mM b-mercaptoethanol.
Solution density was calculated at 4 C using Sednterp program
from buffer composition as 1.00733 g ml1 [29]. The partial spe-
ciﬁc volumes of proteins were calculated at 4 C as 0.7321 ml g1
for TyrRSapm and 0.7309 ml g1 for DTyrRSapm, from the respective
amino acid composition using Sednterp. The data were analyzed by
global nonlinear least squares ﬁtting using SEDPHAT software
(v10.4, 2012) [30]. TyrRSapm data was ﬁtted in monomer–dimer
and monomer–dimer–tetramer model to obtain both molecular
weight and dissociation constant. The DTyrRSapm data both in ab-
sence and presence of reducing agent was ﬁtted in single-species
and monomer–dimer model. During ﬁtting, both molecular weight
and dissociation constant values were allowed to ﬂoat. Molecular
weight (Mr) and dissociation constants were obtained by a mod-
el-dependent method with least chi-square and least rmsd value
[29].2.13. Cysteine reactivity studies
A 40 mM stock solution of DTNB was prepared by weight in
20 mM Tris–HCl (pH 7.4) buffer containing 1 mM EDTA. Molar con-
centration of the stock DTNB solution was determined by measur-
ing absorbance at 324 nm (molar extinction coefﬁcient at
324 nm = 19800 M1 cm1). For reactive cysteine estimation,
absorbance was recorded at 412 nm in Shimadzu UV-2450 Spec-
trophotometer. Protein samples (4 lM) were mixed with excess
concentration of DTNB (2 mM) to ensure complete reaction of
DTNB with free cysteine. Dithiothreitol (DTT)-treated samples
were extensively dialyzed in the presence of 1 mM EDTA to
prevent auto-oxidation of cysteine residues, before DTNB reaction
to ensure the removal of any free DTT in the solution. The
number of reactive cysteines was calculated using a molar extinc-
tion coefﬁcient of 14150 M1 cm1 for native conditions and
13700 M1 cm1 in the presence of 0.2% SDS.
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The ligand binding was monitored by tryptophan ﬂuorescence
quenching method using Hitachi F-7000 ﬂuorometer in 20 mM
Tris–HCl buffer (pH-7.4) containing 16 mM MgCl2 [31]. Constant
temperature was maintained by a circulating water bath. For all
the experiments, concentrations of both TyrRSapm and DTyrRSapm
were kept at 2 lM. The experiments were also repeated in pres-
ence of 27 nM TyrRSapm (henceforth designated as TyrRSapmmono).
The ﬂuorescence intensity was corrected for dilution due to ligand
addition. For tRNA titration, the inner ﬁlter effect was corrected
using the following formula:
Fcorr ¼ Fobs antilog ½ðAex þ AemÞ=2
Where Aex and Aem were absorbance at excitation and emission
wavelength, respectively. The quenching was evaluated from the
ratio of the corrected ﬂuorescence intensity in the presence of
the substrate to that in its absence. The data were ﬁtted to a sin-
gle-binding site equation, using Kyplot (version 2.0 beta 15 (32
bit), Koichi Yoshioka, 1997–2001). Average values were deter-
mined from at least three independent experiments and the plots
were constructed. The standard errors are provided in the table.
3. Results
3.1. DTyrRSapm forms folded structure
To check the integrity and folding pattern of the truncated Tyr-
RSapm, the far-UV CD experiment was performed (Fig. 1A). From the
available crystal structure of TyrRSapm (pdb code: 2J5B), our calcu-
lated helical content of TyrRSapm and DTyrRSapm were 50.6% and
54.3%, respectively. The a-helical contents as estimated from
MRE value at 222 nm (see Section 2) of the far-UV CD spectra are
47.8% and 51.6%, respectively. The close proximity of observed
and expected percentage of a-helical contents showed structural
integrity of DTyrRSapm. The CD spectra in presence of b-mercap-
toethanol also don’t show any signiﬁcant changes indicating that
the secondary structure of DTyrRSapm has not been affected in
presence of the reducing agent.
The near-UV CD spectra of TyrRSapm and DTyrRSapm in pres-
ence and absence of reducing agent are shown in the Fig. 1B.
The nature and intensities of near-UV CD spectra of DTyrRSapm
in absence of b-mercaptoethanol was signiﬁcantly differed from
TyrRSapm spectra (Fig. 1B). The broad positive spectrum of DTyr-
RSapm in the absence of reducing agent throughout the whole
near-UV CD spectrum (250–320 nm) indicated probable forma-
tion of disulﬁde-bridge/bridges upon truncation [32]. In presence
of the reducing agent however the positive spectrum disappeared
and the pattern of spectra is nearly identical with TyrRSapm. The
result reinforced our observation of disulﬁde bond formation in
DTyrRSapm. Summing up the CD data showed that the DTyrRSapm
is well folded and have some additional tertiary interaction
features.3.2. DTyrRSapm is a monomer
It is known that the gel-ﬁltration of a macromolecule not only
depends on its molecular weight but also on its shape [33]. To
avoid ambiguity, the Ferguson plot was constructed by running
several different percentage native-PAGE gels (see Supplementary
information). Fig. 1C showed the plot of (Kr)1/2 vs molecular radius
of TyrRSapm and DTyrRSapm along with four standard proteins. The
red and blue arrows indicate the positions of TyrRSapm and DTyr-
RSapm, respectively. The molecular radius of DTyrRSapm clearly
shows that it is a monomer while TyrRSapm exists as a dimer.To conﬁrm our observation, equilibrium sedimentation study
was performed (Fig. 1D). This method allows the user to determine
the molecular weight of a protein that is independent of its shape.
Three different concentrations were analyzed for TyrRSapm (2, 0.5,
and 0.2 lM). Fitting the data to a monomer–dimer equilibrium
model yielded a good ﬁt with a dissociation constant (Kd) value
of 0.41 lM. Fig. 1D (i), (ii) and (iii) represents the global analysis
of the data for TyrRSapm at 0.2, 0.5 and 2 lM concentration, respec-
tively using monomer–dimer association model. The analysis
yielded a molecular weight of 84134 Da for TyrRSapm, close to the-
oretical value calculated based upon amino acid composition
(84368 Da including extra amino acids present due to His-tagged
extension).
The data ofDTyrRSapm both in absence and presence of reducing
agent ﬁtted best [Fig. 1D (iv) and (v) respectively] using a single-
species model with a molecular weight of 29566 Da, and
29321 Da respectively, close to the theoretical molecular weight
(29112 Da of DTyrRSapm calculated using amino-acid sequence
including extra amino acids present due to His-tagged extension).
The monomer–dimer association model also produced good ﬁt, but
with a very high dissociation constant (Kd = 1.1  106 lM). This
clearly indicated that under our experimental condition, dimer for-
mation is unlikely for DTyrRSapm. By ﬁxing the molecular weight
(29100 Da) and dissociation constant (0.4 lM), the monomer–
dimer association model produced a poor ﬁt in both cases.
3.3. DTyrRSapm forms disulphide bridge
TyrRSapm has 10 Cys residues per monomer, none of them are
involved in disulﬁde bridge formation as evidenced from the crys-
tal structure. The observed decrease in intrinsic ﬂuorescence of
DTyrRSapm (Fig. 2A) may be due to conformation change that
leaves the tryptophan residues more exposed to solvent. Alterna-
tively, the lesser number of tryptophan residues present per mole-
cule (2 in monomeric DTyrRSapm vs 6 in full-length dimeric
TyrRSapm) may also be a contributing factor. To conﬁrm our obser-
vation that intramolecular disulphide bond might have formed in
DTyrRSapm, (containing 8 Cys residues) we did two experiments.
It is known that disulphide bonds quench nearby tryptophan emis-
sion signiﬁcantly [34]. The emission spectra were measured in the
presence and absence of b-mercaptoethanol. Only DTyrRSapm
showed a nearly 4-fold increase in ﬂuorescence intensity in the
presence of the reducing agent, indicating that reduction of disul-
phide-bridge leads to ﬂuorescence enhancement (Fig. 2A). Sec-
ondly, DTNB reaction of TyrRSapm showed 3 reactive Cys under
native condition (Fig. 2B and Table 1), while in presence of 0.2%
SDS all 10 Cys were reactive per monomer, indicating no disul-
phide bonds in TyrRSapm. For DTyrRSapm, there are 8 Cys residues
in N-terminal half and two of them are reactive under either native
condition or in presence of 0.2% SDS. Thus 6 Cys are non-reactive.
After reduction with DTT, DTNB reaction indicated all 8 are acces-
sible (Table 1). The near UV-CD data showed that disulﬁde bridge/
bridges are present in DTyrRSapm structure, but oxidation of some
cysteine residues to sulﬁnic, sulphonic and sulfenic acid are also
equally probable as formation of three disulﬁde bridges are very
unlikely (see Section 4) [35,36]. It may be noted here that in the
crystal structure of TyrRSapm only 7 out of 10 cysteine residues
are visible. Interestingly, all of three invisible cysteine residues ap-
peared to be near the dimeric interface. Among them, Cys 150 and
Cys 151 are adjacent to each other and are likely to form at least
one disulﬁde bond near the dimeric interface.
3.4. Effect of substrates on dimerization of TyrRSapm
It was predicted based on previous model building study that
interaction with cognate tRNA in solution might help in the
(iv)(iii)(ii)(i)
(v)
(A)
(D)
(B) (C)
Fig. 1. Secondary and tertiary environment of TyrRSapm and DTyrRSapm. (A) Far-UV CD spectra. The protein concentration was 4 lM per monomer. (B) Near-UV CD spectra.
The protein concentration was 40 lM/monomer. (C) Molecular weight determination of TyrRSapm and DTyrRSapm by Ferguson plot. Native polyacrylamide gel electrophoresis
was run at various concentration and a graph of retardation coefﬁcient (Kr) versus molecular radius was constructed using our different standard proteins, namely BSA
(66 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa) and lactalbumin (14 kDa), indicated by circles in the curve with molecular weight mentioned in brackets. The
arrows represent the positions of TyrRSapm and DTyrRSapm. (D) Molecular weight and dissociation constant (Kd) determination of TyrRSapm and DTyrRSapm by Analytical
Ultracentrifuge (AUC). Sedimentation equilibrium proﬁles of TyrRSapm [(i)–(iii)] at concentrations 0.2, 0.5 and 2 lM respectively. Panel (iv–v) represent DTyrRSapm at
concentration of 5 lM in absence and in presence of 10 mM b-mercaptoethanol respectively.
594 A. Choudhury, R. Banerjee / FEBS Letters 587 (2013) 590–599formation of productive tRNA/TyrRSapm dimer complex [17]. To
understand the effect of substrates ﬂuorescence anisotropy study
of FITC-labeled TyrRSapm was performed in presence and absence
of different substrates, separately or in combination. The labeled
enzyme retained 80% of tRNA aminoacylation activity to wild-
type TyrRSapm (data not shown). The idea is that at higher con-
centration the enzyme exists as dimer, thus the tumbling rate is
slow, having higher anisotropy value. Upon dilution, it eventually
dissociates into monomer with faster tumbling rate, hence lower
anisotropy value. Thus plotting anisotropy values as a function of
enzyme concentration yields monomer–dimer dissociation con-
stant [27,28]. The monomer–dimer dissociation constant of
FITC-labeled TyrRSapm was found to be 0.67 lM, in good agree-ment with AUC experiment. It proved that labeling of protein
did not perturb monomer–dimer binding equilibrium in solution.
Table 2 showed that the dissociation constant did not change sig-
niﬁcantly only except where all the substrates are present. In the
presence of all substrates, under our experimental condition,
tyrosine and ATP are still available even all of the tRNA is amino-
acylated as tRNA was the limiting substrate. Thus the decrease in
the dissociation constant is likely due to formation of tyrosyl-
adenylate. However, decrease of dimer–monomer dissociation
constant may also be explained on the basis of the fact that when
substrate concentration is used at near or higher concentration
than the Km value, generally the dimer formation is signiﬁcantly
promoted [37].
(i) (ii) (iii)
(B)
(A)
Fig. 2. Fluorescence intensity of TyrRSapm and DTyrRSapm under reducing condition. (A) Fluorescence emission spectra of TyrRSapm and DTyrRSapm in presence of b-
mercaptoethanol. (B) The number of accessible cysteine residues in TyrRSapm and DTyrRSapm. Changes in absorbance at 412 nm due to the release of the product 5-thiolata-2-
nitrobenzoate were recorded in a Shimadzu UV-2450 spectrophotometer.
Table 1
Number of reactive cysteine residues as determined by DTNB reaction: Changes in
absorbance at 412 nm due to the release of the product 5-thiolata-2-nitrobenzoate
were recorded in a Shimadzu UV-2450 spectrophotometer. The number of reactive
cysteines was calculated using a molar extinction coefﬁcient of 14150 M1 cm1 for
native conditions and 13700 M1 cm1 in the presence of 0.2% SDS.
DTNB DTNB + SDS DTNB + SDS + DTT
TyrRSapm 3 10 ND
DTyrRSapm 2 2 8
ND, not determined.
Table 2
Fluorescence anisotropy experiment will FITC-labeled TyrRSapm: Effect of ligands on
the monomer–dimer equilibrium dissociation constants of TyrRSapm. For the samples
saturated with ligands, 1 mM of L-tyrosine, 2 mM of ATP and 5 lM of tRNATyr
separately or together was ﬁrst incubated with the enzyme sample for 30 min at
25 C. FITC labeled proteins were excited at 490 nm and emission was recorded at
525 nm.
Ligand Kd (M)a
None (0.7 ± 0.03)  106
ATP (0.2 ± 0.01)  106
L-Tyrosine (0.3 ± 0.04)  106
tRNATyr (0.9 ± 0.07)  106
ATP + L-tyrosine + tRNATyr (0.07 ± 0.01)  106
a Values are the means of at least three independent experiments with standard
errors indicated.
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The aminoacylation reaction was carried out to follow the en-
tire reaction catalyzed by DTyrRSapm (Eqs. (1) and (2) combined
as described in Section 1). The aminoacylation assay showed thatDTyrRSapm is unable to aminoacylate tRNA in both the presence
and absence of b-mercaptoethanol (Fig. 3A). This is neither surpris-
ing nor unexpected as DTyrRSapm lacks the entire C-terminal anti-
codon-binding domain to bind tRNATyr. It is noteworthy to
mention here that Bst-TyrRS that forms dimeric N-ter TyrRS also
fails to charge tRNA, though it was active in an ATP–PPi exchange
assay, which monitors the tyrosine activation step (Eq. (1) in Sec-
tion 1) [38,39]. TyrRSapm showed similar aminoacylation capability
both in presence and absence of the reducing agent. It may be
noted that from 20 nM to 1 lM concentration (i.e. when the en-
zyme concentration is near or below the dissociation constant of
dimer formation) the aminoacylation capacity of the enzyme was
negligible.3.6. DTyrRSapm and monomeric TyrRSapm can activate and bind small
ligands
The ATP–PPi exchange reaction showed both TyrRSapm and
DTyrRSapm are active in presence and absence of reducing agent
(Fig. 3B). The charging capacity of DTyrRSapm did not improve
in presence of b-mercaptoethanol and in both cases they had
lower charging capability compare to TyrRSapm. Surprisingly, the
TyrRSapmmono (TyrRSapm at 27 nM) still capable of forming
tyrosyl-adenylate, albeit weakly compare to TyrRSapm. However,
despite of our several efforts using different concentration of sub-
strates and enzyme (DTyrRSapm or TyrRSapmmono) we did not able
to determine Km and kcat values with conﬁdence. Thus tryptophan
ﬂuorescence quenching method was employed to determine the
dissociation constant. The dissociation constant is an indication
of the stability of protein–ligand complex. If any change hap-
pened in the active site due to truncation, it would be reﬂected
in the dissociation constant. The result of titrations with all
(A)
(B)
Fig. 3. Functional assay of TyrRSapm and DTyrRSapm. (A) Aminoacylation assay
reactions were carried out at 37 C for 30 min. Tyrosylation of human tRNATyr
transcript was performed in aminoacylation buffer. The amount of radioactivity
retained was determined by liquid scintillation counting. The enzyme and tRNA
concentration were 20 lM and 3 lM respectively. The reaction was repeated with
enzyme concentration of 20 nM to 2 lM. (B) ATP–PPi exchange reaction.
Table 3
Dissociation constants of TyrRSapm and DTyrRSapm: Fluorescence quenching method
(kex = 295 nm and kem = 340 nm) was employed to determine the dissociation
constants in presence of substrates. The data was ﬁtted to single-site binding
equation using Kyplot (version 2.0 beta 15 (32 bit), Koichi Yoshioka, 1997–2001).
Ligands TyrRSapm (M)a DTyrRSapm (M)a TyrRSapmmono
(M)b
ATP (4 ± 0.6)  104 (4 ± 0.7)  104 (7 ± 0.6)  104
L-Tyr (5 ± 0.2)  106 (2 ± 0.1)  106 (3 ± 0.3)  104
ATP + L-Tyr at
saturation
(2 ± 0.1)  103 (7 ± 1)  104 (2 ± 0.2)  103
L-Tyr + ATP at
saturation
(6 ± 0.3)  106 (2 ± 0.03)  106 (3 ± 0.3)  106
tRNATyr (0.40 ± 0.05)  106 (16 ± 2)  106 (12 ± 1)  106
a Values are the means of at least three independent experiments with standard
errors indicated. The concentration of TyrRSapm was 4 lM.
b Concentration of TyrRSapm used was 27 nM.
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cant change in dissociation constant, hence complex stability
(Table 3, Fig. 4A–D). Thus the DTyrRSapm and TyrRSapmmono, in
presence and absence of b-mercaptorthanol can bind smaller sub-
strates with almost equal afﬁnity. In contrast, the nature of
tRNATyr binding isotherm exhibited marked difference (Fig. 4E).
The linear decrease of ﬂuorescence intensity for tRNA binding
to DTyrRSapm or TyrRSapmmono (Fig. 4E) indicated poor binding[40]. The calculated dissociation constant of tRNATyr for TyrRSapm
(0.37 lM) is in good agreement with Km value determined using
yeast tRNATyr (0.49 lM) [17]. The dissociation constant showed
that the TyrRSapm binds its cognate tRNA at least 40- or 30-fold
tighter than DTyrRSapm and TyrRSapmmono (15 lM and 12 lM
respectively). This is not unanticipated as the entire C-terminal
domains either missing or unavailable for interaction with antico-
don-binding domain of tRNATyr.4. Discussion
The analytical ultracentrifuge study of TyrRSapm showed that at
all concentration tested here (0.2, 0.5 and 2 lM), the protein exists
both as monomer and dimer in solution, with an estimated disso-
ciation constant of 0.41 lM. This is in sharp contrast to the previ-
ously reported dissociation constant of the N-terminal fragment of
Bst-TyrRS (84 pM) [2,18] and at least 4-fold weaker to N. crassa
mitochondrial TyrRS and human N-terminal catalytic domain of
TyrRS, namely TyrRSmini (0.1 lM) [19,20]. The higher dissociation
constants of later TyrRSs had been attributed to lesser buried sur-
face area than Bst-TyrRS [17]. Previous study revealed that Tyr-
RSapm has the least buried surface value compare to other TyrRSs
(2360 Å2 for TyrRSapm vs 2970–3300 Å2 for other TyrRSs) [17]. Con-
sidering that buried surface area for TyrRSapm is 20–30% lower
compare to other TyrRSs, the weaker monomer–dimer dissociation
constant of TyrRSapm (0.41 lM) seems reasonable. The least buried
dimeric interface area of TyrRSapm among all known TyrRSs may be
accredited to the non-canonical dimeric interface due to the pres-
ence of a unique 20-residue long a-helix CP1-domain [17], which
is known to play central role in dimerization in all TyrRSs. It was
predicted that in spite of peculiar CP1 domain structure in Tyr-
RSapm, it still plays pivotal role in dimer formation in TyrRSapm
[17]. However from our observation of existence of monomeric
DTyrRSapm containing the entire CP1 domain in solution, it seems
apparent that the CP1 domain may not solely responsible for
dimerization in full-length TyrRSapm. One of the implications of
the above observation is that the carboxy-terminal domain stabi-
lizes dimer formation of TyrRSapm through indirect interactions.
The existence of monomer in presence of the reducing agent
indicated that disulphide bond formation is not the driving force
for dimer to monomer transition. Though it is generally believed
that the disulﬁde-bridges stabilize protein structures, but several
reports indicated and it is well established that some of them have
a distinct role in protein function regulation [41,42]. This second
group of disulﬁde bonds found to contribute very little to stabiliza-
tion, rather act as reversible redox switches [43]. Furthermore, the
oxidation of cysteine residues under oxidative stress is also impli-
cated in many diseases such as stroke, cancer, diabetes, neurolog-
ical disorders, ischemia, etc. to name a few [44–46]. Recently, Ling
and Söll reported that oxidation of a cysteine residue in ThrRS edit-
ing site causes serine misincorporation and retarded growth of
Escherichia coli in presence of hydrogen peroxide [47]. The thiol
group of MetRS, GluRS and ThrRS also found to be oxidized in Hela
cells [48]. In all the above examples, cysteine residues are con-
verted to sulﬁnic acid [49]. Some recent reports also indicated in-
creased misacylated Met-tRNA species under oxidative stress and
viral infection [50]. The DTyrRSapm containing 8 cysteine residues
that are susceptible to oxidation and readily forms disulphide-
bridge. However it is very unlikely that all the 6 cysteine residues
are involved in disulﬁde-bridge formation as it would lead to inac-
tive enzyme. Rather it may be speculated that some of the cysteine
residues may have oxidized easily. Facile oxidation of cysteine res-
idues of DTyrRSapm as reported here, provided an interesting hint
that under hypoxia and/or oxidative stress, some of the cysteine
of TyrRSapm may be oxidized in vivo leading to mistranslation,
(A) (B) (C)
(D) (E)
Fig. 4. Interaction of L-tyrosine, ATP and tRNA with TyrRSapm and DTyrRSapm. (A–E) Quenching of the intrinsic ﬂuorescence of TyrRSapm and DTyrRSapm by ATP in absence (A)
or in presence of saturating amount of L-tyrosine (B) and L-tyrosine in absence (C) or presence of saturating amount of ATP (D). The quenching curve of tRNATyr titration is also
represented (E). TyrRSapm concentration was either 27 nM or 2 lM and DTyrRSapm concentration was 2 lM.
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fenses by producing statistical proteins [49] remains to be seen.
Another indirect evidence for formation of monomer comes
from the aminoacylation assay. When used in nM range during
aminoacylation the enzyme was unable to charge tRNATyr. The
activity was only detectable when the enzyme concentration used
was above 1 lM. This is not unexpected, as most of the enzyme
molecule exists as dimer at or above 1 lM concentration. It is note-
worthy to mention here that in presence of all the substrates the
monomer–dimer dissociation constant decreased signiﬁcantly
(<0.1 lM), however it had not been reﬂected in the aminoacylation
assay. The observation is hard to justify, one apparent explanation
may be that the human tRNATyr used in the aminoacylation assay is
not the optimal substrate for TyrRSapm. Alternatively, the aminoa-
cylation assay and measurement of the monomer–dimer dissocia-
tion constant are performed under different conditions. In the
assays, measuring the monomer–dimer dissociation constant, both
tyrosine and ATP are present at saturating concentrations, whereas
in the aminoacylation assays, the concentration of tyrosine was
subsurating. Since most of the enzyme will be present in the unli-
ganded form under these conditions, one would expect the disso-
ciation constant to be 0.7 lM.
It is well established that human full-length TyrRS in vivo
splits into two parts by natural proteolysis and both fragments
have cytokine activities [51]. Also, it had been reported that the
nuclear export signal of yeast Yap1p is regulated by reversible
disulﬁde bond formation [52]. However, it is very difﬁcult to pre-
dict and beyond the scope of our present study whether the
monomeric DTyrRSapm exists in vivo and plays any non-canonical
role in the virus lifecycle. Secondly, the low aminoacylation activ-
ity of the enzyme in vitro is another surprising feature. The turn-
over number (kcat) for tRNATyr of TyrRSapm is 0.126 s1 when
native yeast tRNATyr was used as substrate [17]. This turnover
number is at least 10-times lower than the other TyrRSs reported
except bovine liver enzyme. It is noteworthy to mention here that
TyrRS and TrpRS (Tryptophanyl-tRNA synthetase) though belong-ing to class I, follow kinetics like class II enzymes, i.e., release of
the product is not rate-limiting for bacterial TyrRSs. In general the
eukaryotic TyrRSs have lower kcat values than their bacterial
counterparts [23]. The decrease in kcat value normally attributed
to structural changes affect the rate-limiting step of the en-
zyme-catalyzed reaction [53]. In this respect, TyrRSapm seems to
behave more like eukaryotic counterpart. However, it may indi-
cate probable requirement of some other factors including host
factors in vivo for activity enhancement as reported previously
for Methanothermobacter thermoautotrophicus leucyl-tRNA synthe-
tase (LeuRS), whose kcat value was enhanced by 8-fold in presence
of archaeal EF-1a.GTP or EF-1a.GTP [54].
Furthermore, though the truncated enzyme (DTyrRSapm) can
bind its cognate tRNA substrate loosely, it fails to transfer the
activated tyrosine to tRNA, probably due to the lack of C-terminal
anticodon-binding domain that helps in proper positioning of the
30-end of cognate tRNA at the catalytic center of the other subunit
of the dimer [2]. The capability of monomeric TyrRSapm as reported
here, to bind and activate tyrosine but can’t transfer the activated
amino acid to its cognate tRNA is reminiscent of the hypothesis
that the primordial aminoacyl-tRNA synthetases (aaRSs) activated
small molecules using ATP, but did not aminoacylate tRNA [55,56].
Finally, whether the unusually high cysteine content in TyrRSapm
primary sequence may be advantageous for invading the host
organism is remain to be seen.
5. Conclusion
To the best of our knowledge, this is the ﬁrst report of mono-
meric TyrRS that can activate tyrosine. Previous study with
BstTyrRS enzyme clearly showed that the monomeric form is com-
pletely inactive with respect to substrate binding and activation
[39]. Finally, our observation that the unique CP1 domain of Tyr-
RSapm may not be only factor responsible for non-canonical dimer
formation in full-length enzyme, the C-terminal domain also has a
indirect role is unique among the TyrRS systems studied so far.
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